nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium stibogluconate—TOP1—Irinotecan—pancreatic cancer	0.81	1	CbGbCtD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—TNFRSF10B—pancreatic cancer	0.00449	0.116	CbGpPWpGaD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—TNFSF10—pancreatic cancer	0.00299	0.0774	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	0.00297	0.0768	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	0.00216	0.0558	CbGpPWpGaD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—BCL2L1—pancreatic cancer	0.00188	0.0485	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	0.00152	0.0393	CbGpPWpGaD
Sodium stibogluconate—TOP1—Circadian rythm related genes—AHR—pancreatic cancer	0.0015	0.0387	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	0.00136	0.0353	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	0.00135	0.0348	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	0.00118	0.0304	CbGpPWpGaD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—CASP3—pancreatic cancer	0.00116	0.03	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	0.00116	0.0299	CbGpPWpGaD
Sodium stibogluconate—TOP1—Circadian rythm related genes—EZH2—pancreatic cancer	0.00113	0.0292	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	0.000991	0.0256	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	0.000896	0.0232	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	0.000868	0.0224	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	0.000852	0.022	CbGpPWpGaD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—TNF—pancreatic cancer	0.000844	0.0218	CbGpPWpGaD
Sodium stibogluconate—TOP1—Circadian rythm related genes—TYMS—pancreatic cancer	0.000818	0.0212	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	0.000646	0.0167	CbGpPWpGaD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—AKT1—pancreatic cancer	0.000628	0.0162	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	0.000618	0.016	CbGpPWpGaD
Sodium stibogluconate—TOP1—Circadian rythm related genes—PPARG—pancreatic cancer	0.00058	0.015	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	0.000475	0.0123	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	0.000441	0.0114	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	0.000429	0.0111	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	0.000425	0.011	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	0.000414	0.0107	CbGpPWpGaD
Sodium stibogluconate—TOP1—Circadian rythm related genes—PTEN—pancreatic cancer	0.000398	0.0103	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	0.000384	0.00993	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	0.000374	0.00967	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	0.000344	0.0089	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	0.000343	0.00888	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	0.000337	0.00871	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	0.000321	0.00829	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	0.000318	0.00822	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	0.000292	0.00756	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	0.000283	0.00731	CbGpPWpGaD
Sodium stibogluconate—Urticaria—Tamoxifen—pancreatic cancer	0.000276	0.00182	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Tamoxifen—pancreatic cancer	0.000274	0.00181	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Erlotinib—pancreatic cancer	0.000271	0.0018	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Erlotinib—pancreatic cancer	0.000271	0.0018	CcSEcCtD
Sodium stibogluconate—TOP1—Circadian rythm related genes—TP53—pancreatic cancer	0.000271	0.00702	CbGpPWpGaD
Sodium stibogluconate—Vision blurred—Fluorouracil—pancreatic cancer	0.000271	0.00179	CcSEcCtD
Sodium stibogluconate—Phlebitis—Epirubicin—pancreatic cancer	0.00027	0.00178	CcSEcCtD
Sodium stibogluconate—Syncope—Irinotecan—pancreatic cancer	0.000269	0.00178	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Sunitinib—pancreatic cancer	0.000267	0.00177	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Sunitinib—pancreatic cancer	0.000265	0.00175	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Irinotecan—pancreatic cancer	0.000264	0.00174	CcSEcCtD
Sodium stibogluconate—Acute coronary syndrome—Docetaxel—pancreatic cancer	0.000262	0.00173	CcSEcCtD
Sodium stibogluconate—Renal failure—Docetaxel—pancreatic cancer	0.000261	0.00173	CcSEcCtD
Sodium stibogluconate—Myocardial infarction—Docetaxel—pancreatic cancer	0.00026	0.00172	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Sunitinib—pancreatic cancer	0.000258	0.00171	CcSEcCtD
Sodium stibogluconate—Sepsis—Doxorubicin—pancreatic cancer	0.000257	0.0017	CcSEcCtD
Sodium stibogluconate—Fatigue—Sunitinib—pancreatic cancer	0.000256	0.0017	CcSEcCtD
Sodium stibogluconate—Cardiac failure congestive—Epirubicin—pancreatic cancer	0.000256	0.00169	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000256	0.00169	CcSEcCtD
Sodium stibogluconate—Constipation—Sunitinib—pancreatic cancer	0.000254	0.00168	CcSEcCtD
Sodium stibogluconate—Renal failure acute—Epirubicin—pancreatic cancer	0.000252	0.00166	CcSEcCtD
Sodium stibogluconate—Phlebitis—Doxorubicin—pancreatic cancer	0.000249	0.00165	CcSEcCtD
Sodium stibogluconate—Asthenia—Tamoxifen—pancreatic cancer	0.000249	0.00165	CcSEcCtD
Sodium stibogluconate—Convulsion—Fluorouracil—pancreatic cancer	0.000249	0.00165	CcSEcCtD
Sodium stibogluconate—Chest pain—Gemcitabine—pancreatic cancer	0.000249	0.00165	CcSEcCtD
Sodium stibogluconate—Asthenia—Erlotinib—pancreatic cancer	0.000246	0.00163	CcSEcCtD
Sodium stibogluconate—Pruritus—Tamoxifen—pancreatic cancer	0.000246	0.00162	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000245	0.00162	CcSEcCtD
Sodium stibogluconate—Oedema—Irinotecan—pancreatic cancer	0.000245	0.00162	CcSEcCtD
Sodium stibogluconate—Chest pain—Fluorouracil—pancreatic cancer	0.000245	0.00162	CcSEcCtD
Sodium stibogluconate—Renal impairment—Epirubicin—pancreatic cancer	0.000244	0.00161	CcSEcCtD
Sodium stibogluconate—Infection—Irinotecan—pancreatic cancer	0.000243	0.00161	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000243	0.00161	CcSEcCtD
Sodium stibogluconate—Pruritus—Erlotinib—pancreatic cancer	0.000243	0.00161	CcSEcCtD
Sodium stibogluconate—Shock—Irinotecan—pancreatic cancer	0.000241	0.00159	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	0.000239	0.00617	CbGpPWpGaD
Sodium stibogluconate—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000239	0.00158	CcSEcCtD
Sodium stibogluconate—Oedema—Gemcitabine—pancreatic cancer	0.000239	0.00158	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Tamoxifen—pancreatic cancer	0.000237	0.00157	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Docetaxel—pancreatic cancer	0.000237	0.00157	CcSEcCtD
Sodium stibogluconate—Cerebrovascular accident—Epirubicin—pancreatic cancer	0.000237	0.00157	CcSEcCtD
Sodium stibogluconate—Cardiac failure congestive—Doxorubicin—pancreatic cancer	0.000237	0.00157	CcSEcCtD
Sodium stibogluconate—Infection—Gemcitabine—pancreatic cancer	0.000237	0.00157	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000237	0.00157	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Sunitinib—pancreatic cancer	0.000235	0.00155	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Sunitinib—pancreatic cancer	0.000235	0.00155	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Erlotinib—pancreatic cancer	0.000235	0.00155	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000235	0.00155	CcSEcCtD
Sodium stibogluconate—Oedema—Fluorouracil—pancreatic cancer	0.000235	0.00155	CcSEcCtD
Sodium stibogluconate—Anorexia—Irinotecan—pancreatic cancer	0.000233	0.00154	CcSEcCtD
Sodium stibogluconate—Hyponatraemia—Epirubicin—pancreatic cancer	0.000233	0.00154	CcSEcCtD
Sodium stibogluconate—Infection—Fluorouracil—pancreatic cancer	0.000233	0.00154	CcSEcCtD
Sodium stibogluconate—Renal failure acute—Doxorubicin—pancreatic cancer	0.000233	0.00154	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000231	0.00153	CcSEcCtD
Sodium stibogluconate—Dizziness—Tamoxifen—pancreatic cancer	0.00023	0.00152	CcSEcCtD
Sodium stibogluconate—Tachycardia—Fluorouracil—pancreatic cancer	0.000229	0.00151	CcSEcCtD
Sodium stibogluconate—Hypotension—Irinotecan—pancreatic cancer	0.000229	0.00151	CcSEcCtD
Sodium stibogluconate—Anorexia—Gemcitabine—pancreatic cancer	0.000227	0.0015	CcSEcCtD
Sodium stibogluconate—Dizziness—Erlotinib—pancreatic cancer	0.000227	0.0015	CcSEcCtD
Sodium stibogluconate—Renal impairment—Doxorubicin—pancreatic cancer	0.000226	0.00149	CcSEcCtD
Sodium stibogluconate—Anorexia—Fluorouracil—pancreatic cancer	0.000224	0.00148	CcSEcCtD
Sodium stibogluconate—Hypotension—Gemcitabine—pancreatic cancer	0.000223	0.00147	CcSEcCtD
Sodium stibogluconate—Vomiting—Tamoxifen—pancreatic cancer	0.000221	0.00146	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Irinotecan—pancreatic cancer	0.00022	0.00145	CcSEcCtD
Sodium stibogluconate—Cerebrovascular accident—Doxorubicin—pancreatic cancer	0.000219	0.00145	CcSEcCtD
Sodium stibogluconate—Hypotension—Fluorouracil—pancreatic cancer	0.000219	0.00145	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Sunitinib—pancreatic cancer	0.000219	0.00145	CcSEcCtD
Sodium stibogluconate—Rash—Tamoxifen—pancreatic cancer	0.000219	0.00145	CcSEcCtD
Sodium stibogluconate—Dermatitis—Tamoxifen—pancreatic cancer	0.000219	0.00145	CcSEcCtD
Sodium stibogluconate—Vomiting—Erlotinib—pancreatic cancer	0.000218	0.00144	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Irinotecan—pancreatic cancer	0.000218	0.00144	CcSEcCtD
Sodium stibogluconate—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000218	0.00144	CcSEcCtD
Sodium stibogluconate—Headache—Tamoxifen—pancreatic cancer	0.000217	0.00144	CcSEcCtD
Sodium stibogluconate—Rash—Erlotinib—pancreatic cancer	0.000217	0.00143	CcSEcCtD
Sodium stibogluconate—Dermatitis—Erlotinib—pancreatic cancer	0.000216	0.00143	CcSEcCtD
Sodium stibogluconate—Dehydration—Epirubicin—pancreatic cancer	0.000216	0.00143	CcSEcCtD
Sodium stibogluconate—Hyponatraemia—Doxorubicin—pancreatic cancer	0.000216	0.00143	CcSEcCtD
Sodium stibogluconate—Headache—Erlotinib—pancreatic cancer	0.000215	0.00142	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Gemcitabine—pancreatic cancer	0.000214	0.00142	CcSEcCtD
Sodium stibogluconate—Asthenia—Sunitinib—pancreatic cancer	0.000213	0.00141	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Irinotecan—pancreatic cancer	0.000213	0.00141	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Docetaxel—pancreatic cancer	0.000213	0.00141	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Gemcitabine—pancreatic cancer	0.000213	0.00141	CcSEcCtD
Sodium stibogluconate—Hypokalaemia—Epirubicin—pancreatic cancer	0.000211	0.0014	CcSEcCtD
Sodium stibogluconate—Fatigue—Irinotecan—pancreatic cancer	0.000211	0.0014	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Fluorouracil—pancreatic cancer	0.000211	0.00139	CcSEcCtD
Sodium stibogluconate—Pruritus—Sunitinib—pancreatic cancer	0.00021	0.00139	CcSEcCtD
Sodium stibogluconate—Constipation—Irinotecan—pancreatic cancer	0.000209	0.00138	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Fluorouracil—pancreatic cancer	0.000209	0.00138	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Gemcitabine—pancreatic cancer	0.000207	0.00137	CcSEcCtD
Sodium stibogluconate—Nausea—Tamoxifen—pancreatic cancer	0.000206	0.00136	CcSEcCtD
Sodium stibogluconate—Fatigue—Gemcitabine—pancreatic cancer	0.000206	0.00136	CcSEcCtD
Sodium stibogluconate—Constipation—Gemcitabine—pancreatic cancer	0.000204	0.00135	CcSEcCtD
Sodium stibogluconate—Nausea—Erlotinib—pancreatic cancer	0.000204	0.00135	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Fluorouracil—pancreatic cancer	0.000204	0.00135	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Sunitinib—pancreatic cancer	0.000203	0.00135	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Docetaxel—pancreatic cancer	0.000203	0.00134	CcSEcCtD
Sodium stibogluconate—Abdominal distension—Epirubicin—pancreatic cancer	0.000202	0.00134	CcSEcCtD
Sodium stibogluconate—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000201	0.00133	CcSEcCtD
Sodium stibogluconate—Dysphagia—Epirubicin—pancreatic cancer	0.000201	0.00133	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.0002	0.00132	CcSEcCtD
Sodium stibogluconate—Dehydration—Doxorubicin—pancreatic cancer	0.0002	0.00132	CcSEcCtD
Sodium stibogluconate—Dizziness—Sunitinib—pancreatic cancer	0.000197	0.0013	CcSEcCtD
Sodium stibogluconate—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000196	0.00129	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Irinotecan—pancreatic cancer	0.000194	0.00128	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Irinotecan—pancreatic cancer	0.000194	0.00128	CcSEcCtD
Sodium stibogluconate—Bronchitis—Epirubicin—pancreatic cancer	0.000193	0.00128	CcSEcCtD
Sodium stibogluconate—Vomiting—Sunitinib—pancreatic cancer	0.000189	0.00125	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Gemcitabine—pancreatic cancer	0.000189	0.00125	CcSEcCtD
Sodium stibogluconate—Rash—Sunitinib—pancreatic cancer	0.000187	0.00124	CcSEcCtD
Sodium stibogluconate—Dermatitis—Sunitinib—pancreatic cancer	0.000187	0.00124	CcSEcCtD
Sodium stibogluconate—Abdominal distension—Doxorubicin—pancreatic cancer	0.000187	0.00124	CcSEcCtD
Sodium stibogluconate—Urticaria—Fluorouracil—pancreatic cancer	0.000186	0.00123	CcSEcCtD
Sodium stibogluconate—Headache—Sunitinib—pancreatic cancer	0.000186	0.00123	CcSEcCtD
Sodium stibogluconate—Syncope—Docetaxel—pancreatic cancer	0.000186	0.00123	CcSEcCtD
Sodium stibogluconate—Dysphagia—Doxorubicin—pancreatic cancer	0.000186	0.00123	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Fluorouracil—pancreatic cancer	0.000185	0.00123	CcSEcCtD
Sodium stibogluconate—Palpitations—Docetaxel—pancreatic cancer	0.000183	0.00121	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Docetaxel—pancreatic cancer	0.000182	0.00121	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Irinotecan—pancreatic cancer	0.00018	0.00119	CcSEcCtD
Sodium stibogluconate—Convulsion—Docetaxel—pancreatic cancer	0.00018	0.00119	CcSEcCtD
Sodium stibogluconate—Bronchitis—Doxorubicin—pancreatic cancer	0.000179	0.00118	CcSEcCtD
Sodium stibogluconate—Chest pain—Docetaxel—pancreatic cancer	0.000177	0.00117	CcSEcCtD
Sodium stibogluconate—Nausea—Sunitinib—pancreatic cancer	0.000177	0.00117	CcSEcCtD
Sodium stibogluconate—Renal failure—Epirubicin—pancreatic cancer	0.000176	0.00116	CcSEcCtD
Sodium stibogluconate—Asthenia—Irinotecan—pancreatic cancer	0.000176	0.00116	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000173	0.00114	CcSEcCtD
Sodium stibogluconate—Asthenia—Gemcitabine—pancreatic cancer	0.000171	0.00113	CcSEcCtD
Sodium stibogluconate—Oedema—Docetaxel—pancreatic cancer	0.000169	0.00112	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000169	0.00112	CcSEcCtD
Sodium stibogluconate—Pruritus—Gemcitabine—pancreatic cancer	0.000169	0.00112	CcSEcCtD
Sodium stibogluconate—Infection—Docetaxel—pancreatic cancer	0.000168	0.00111	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Irinotecan—pancreatic cancer	0.000168	0.00111	CcSEcCtD
Sodium stibogluconate—Shock—Docetaxel—pancreatic cancer	0.000167	0.0011	CcSEcCtD
Sodium stibogluconate—Pruritus—Fluorouracil—pancreatic cancer	0.000166	0.0011	CcSEcCtD
Sodium stibogluconate—Tachycardia—Docetaxel—pancreatic cancer	0.000165	0.00109	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Gemcitabine—pancreatic cancer	0.000163	0.00108	CcSEcCtD
Sodium stibogluconate—Renal failure—Doxorubicin—pancreatic cancer	0.000163	0.00108	CcSEcCtD
Sodium stibogluconate—Dizziness—Irinotecan—pancreatic cancer	0.000162	0.00107	CcSEcCtD
Sodium stibogluconate—Anorexia—Docetaxel—pancreatic cancer	0.000161	0.00107	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Fluorouracil—pancreatic cancer	0.00016	0.00106	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Epirubicin—pancreatic cancer	0.00016	0.00106	CcSEcCtD
Sodium stibogluconate—Hypotension—Docetaxel—pancreatic cancer	0.000158	0.00105	CcSEcCtD
Sodium stibogluconate—Vomiting—Irinotecan—pancreatic cancer	0.000156	0.00103	CcSEcCtD
Sodium stibogluconate—Dizziness—Fluorouracil—pancreatic cancer	0.000155	0.00103	CcSEcCtD
Sodium stibogluconate—Rash—Irinotecan—pancreatic cancer	0.000154	0.00102	CcSEcCtD
Sodium stibogluconate—Dermatitis—Irinotecan—pancreatic cancer	0.000154	0.00102	CcSEcCtD
Sodium stibogluconate—Headache—Irinotecan—pancreatic cancer	0.000153	0.00101	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Docetaxel—pancreatic cancer	0.000152	0.00101	CcSEcCtD
Sodium stibogluconate—Vomiting—Gemcitabine—pancreatic cancer	0.000152	0.001	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Docetaxel—pancreatic cancer	0.000151	0.000998	CcSEcCtD
Sodium stibogluconate—Rash—Gemcitabine—pancreatic cancer	0.00015	0.000995	CcSEcCtD
Sodium stibogluconate—Dermatitis—Gemcitabine—pancreatic cancer	0.00015	0.000994	CcSEcCtD
Sodium stibogluconate—Headache—Gemcitabine—pancreatic cancer	0.000149	0.000988	CcSEcCtD
Sodium stibogluconate—Vomiting—Fluorouracil—pancreatic cancer	0.000149	0.000986	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000148	0.000979	CcSEcCtD
Sodium stibogluconate—Rash—Fluorouracil—pancreatic cancer	0.000148	0.000978	CcSEcCtD
Sodium stibogluconate—Dermatitis—Fluorouracil—pancreatic cancer	0.000148	0.000977	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Docetaxel—pancreatic cancer	0.000147	0.000973	CcSEcCtD
Sodium stibogluconate—Headache—Fluorouracil—pancreatic cancer	0.000147	0.000972	CcSEcCtD
Sodium stibogluconate—Fatigue—Docetaxel—pancreatic cancer	0.000146	0.000965	CcSEcCtD
Sodium stibogluconate—Nausea—Irinotecan—pancreatic cancer	0.000145	0.000962	CcSEcCtD
Sodium stibogluconate—Constipation—Docetaxel—pancreatic cancer	0.000145	0.000957	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Epirubicin—pancreatic cancer	0.000144	0.00095	CcSEcCtD
Sodium stibogluconate—Nausea—Gemcitabine—pancreatic cancer	0.000142	0.000937	CcSEcCtD
Sodium stibogluconate—Nausea—Fluorouracil—pancreatic cancer	0.000139	0.000921	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000138	0.000915	CcSEcCtD
Sodium stibogluconate—Flatulence—Epirubicin—pancreatic cancer	0.000138	0.000912	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Epirubicin—pancreatic cancer	0.000137	0.000906	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Docetaxel—pancreatic cancer	0.000134	0.000885	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Docetaxel—pancreatic cancer	0.000134	0.000885	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Doxorubicin—pancreatic cancer	0.000133	0.000879	CcSEcCtD
Sodium stibogluconate—Vision blurred—Epirubicin—pancreatic cancer	0.000132	0.000872	CcSEcCtD
Sodium stibogluconate—Flatulence—Doxorubicin—pancreatic cancer	0.000128	0.000844	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Doxorubicin—pancreatic cancer	0.000127	0.000838	CcSEcCtD
Sodium stibogluconate—Syncope—Epirubicin—pancreatic cancer	0.000125	0.00083	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Docetaxel—pancreatic cancer	0.000125	0.000825	CcSEcCtD
Sodium stibogluconate—Palpitations—Epirubicin—pancreatic cancer	0.000124	0.000818	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Epirubicin—pancreatic cancer	0.000123	0.000813	CcSEcCtD
Sodium stibogluconate—Vision blurred—Doxorubicin—pancreatic cancer	0.000122	0.000807	CcSEcCtD
Sodium stibogluconate—Asthenia—Docetaxel—pancreatic cancer	0.000121	0.000803	CcSEcCtD
Sodium stibogluconate—Convulsion—Epirubicin—pancreatic cancer	0.000121	0.000802	CcSEcCtD
Sodium stibogluconate—Pruritus—Docetaxel—pancreatic cancer	0.00012	0.000792	CcSEcCtD
Sodium stibogluconate—Chest pain—Epirubicin—pancreatic cancer	0.000119	0.000788	CcSEcCtD
Sodium stibogluconate—Anxiety—Epirubicin—pancreatic cancer	0.000119	0.000785	CcSEcCtD
Sodium stibogluconate—Syncope—Doxorubicin—pancreatic cancer	0.000116	0.000768	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Docetaxel—pancreatic cancer	0.000116	0.000766	CcSEcCtD
Sodium stibogluconate—Palpitations—Doxorubicin—pancreatic cancer	0.000114	0.000757	CcSEcCtD
Sodium stibogluconate—Oedema—Epirubicin—pancreatic cancer	0.000114	0.000755	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000114	0.000755	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000114	0.000752	CcSEcCtD
Sodium stibogluconate—Infection—Epirubicin—pancreatic cancer	0.000113	0.00075	CcSEcCtD
Sodium stibogluconate—Shock—Epirubicin—pancreatic cancer	0.000112	0.000743	CcSEcCtD
Sodium stibogluconate—Convulsion—Doxorubicin—pancreatic cancer	0.000112	0.000742	CcSEcCtD
Sodium stibogluconate—Dizziness—Docetaxel—pancreatic cancer	0.000112	0.00074	CcSEcCtD
Sodium stibogluconate—Tachycardia—Epirubicin—pancreatic cancer	0.000111	0.000737	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Epirubicin—pancreatic cancer	0.00011	0.00073	CcSEcCtD
Sodium stibogluconate—Chest pain—Doxorubicin—pancreatic cancer	0.00011	0.000729	CcSEcCtD
Sodium stibogluconate—Anxiety—Doxorubicin—pancreatic cancer	0.00011	0.000726	CcSEcCtD
Sodium stibogluconate—Anorexia—Epirubicin—pancreatic cancer	0.000109	0.00072	CcSEcCtD
Sodium stibogluconate—Vomiting—Docetaxel—pancreatic cancer	0.000108	0.000712	CcSEcCtD
Sodium stibogluconate—Rash—Docetaxel—pancreatic cancer	0.000107	0.000706	CcSEcCtD
Sodium stibogluconate—Hypotension—Epirubicin—pancreatic cancer	0.000107	0.000706	CcSEcCtD
Sodium stibogluconate—Dermatitis—Docetaxel—pancreatic cancer	0.000107	0.000705	CcSEcCtD
Sodium stibogluconate—Headache—Docetaxel—pancreatic cancer	0.000106	0.000701	CcSEcCtD
Sodium stibogluconate—Oedema—Doxorubicin—pancreatic cancer	0.000106	0.000699	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000106	0.000699	CcSEcCtD
Sodium stibogluconate—Infection—Doxorubicin—pancreatic cancer	0.000105	0.000694	CcSEcCtD
Sodium stibogluconate—Shock—Doxorubicin—pancreatic cancer	0.000104	0.000687	CcSEcCtD
Sodium stibogluconate—Tachycardia—Doxorubicin—pancreatic cancer	0.000103	0.000682	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Epirubicin—pancreatic cancer	0.000103	0.000678	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000102	0.000675	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Epirubicin—pancreatic cancer	0.000102	0.000673	CcSEcCtD
Sodium stibogluconate—Anorexia—Doxorubicin—pancreatic cancer	0.000101	0.000666	CcSEcCtD
Sodium stibogluconate—Nausea—Docetaxel—pancreatic cancer	0.000101	0.000665	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Epirubicin—pancreatic cancer	9.92e-05	0.000656	CcSEcCtD
Sodium stibogluconate—Hypotension—Doxorubicin—pancreatic cancer	9.87e-05	0.000653	CcSEcCtD
Sodium stibogluconate—Fatigue—Epirubicin—pancreatic cancer	9.84e-05	0.000651	CcSEcCtD
Sodium stibogluconate—Constipation—Epirubicin—pancreatic cancer	9.76e-05	0.000646	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Doxorubicin—pancreatic cancer	9.49e-05	0.000627	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Doxorubicin—pancreatic cancer	9.42e-05	0.000623	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Epirubicin—pancreatic cancer	9.34e-05	0.000617	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Doxorubicin—pancreatic cancer	9.18e-05	0.000607	CcSEcCtD
Sodium stibogluconate—Fatigue—Doxorubicin—pancreatic cancer	9.11e-05	0.000602	CcSEcCtD
Sodium stibogluconate—Urticaria—Epirubicin—pancreatic cancer	9.07e-05	0.0006	CcSEcCtD
Sodium stibogluconate—Constipation—Doxorubicin—pancreatic cancer	9.03e-05	0.000597	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Epirubicin—pancreatic cancer	9.03e-05	0.000597	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Epirubicin—pancreatic cancer	9.03e-05	0.000597	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Doxorubicin—pancreatic cancer	8.64e-05	0.000571	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Epirubicin—pancreatic cancer	8.41e-05	0.000556	CcSEcCtD
Sodium stibogluconate—Urticaria—Doxorubicin—pancreatic cancer	8.39e-05	0.000555	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Doxorubicin—pancreatic cancer	8.35e-05	0.000552	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Doxorubicin—pancreatic cancer	8.35e-05	0.000552	CcSEcCtD
Sodium stibogluconate—Asthenia—Epirubicin—pancreatic cancer	8.19e-05	0.000542	CcSEcCtD
Sodium stibogluconate—Pruritus—Epirubicin—pancreatic cancer	8.08e-05	0.000534	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Epirubicin—pancreatic cancer	7.81e-05	0.000517	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Doxorubicin—pancreatic cancer	7.78e-05	0.000515	CcSEcCtD
Sodium stibogluconate—Asthenia—Doxorubicin—pancreatic cancer	7.58e-05	0.000501	CcSEcCtD
Sodium stibogluconate—Dizziness—Epirubicin—pancreatic cancer	7.55e-05	0.000499	CcSEcCtD
Sodium stibogluconate—Pruritus—Doxorubicin—pancreatic cancer	7.47e-05	0.000494	CcSEcCtD
Sodium stibogluconate—Vomiting—Epirubicin—pancreatic cancer	7.26e-05	0.00048	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Doxorubicin—pancreatic cancer	7.23e-05	0.000478	CcSEcCtD
Sodium stibogluconate—Rash—Epirubicin—pancreatic cancer	7.2e-05	0.000476	CcSEcCtD
Sodium stibogluconate—Dermatitis—Epirubicin—pancreatic cancer	7.19e-05	0.000476	CcSEcCtD
Sodium stibogluconate—Headache—Epirubicin—pancreatic cancer	7.15e-05	0.000473	CcSEcCtD
Sodium stibogluconate—Dizziness—Doxorubicin—pancreatic cancer	6.99e-05	0.000462	CcSEcCtD
Sodium stibogluconate—Nausea—Epirubicin—pancreatic cancer	6.78e-05	0.000449	CcSEcCtD
Sodium stibogluconate—Vomiting—Doxorubicin—pancreatic cancer	6.72e-05	0.000444	CcSEcCtD
Sodium stibogluconate—Rash—Doxorubicin—pancreatic cancer	6.66e-05	0.000441	CcSEcCtD
Sodium stibogluconate—Dermatitis—Doxorubicin—pancreatic cancer	6.65e-05	0.00044	CcSEcCtD
Sodium stibogluconate—Headache—Doxorubicin—pancreatic cancer	6.62e-05	0.000438	CcSEcCtD
Sodium stibogluconate—Nausea—Doxorubicin—pancreatic cancer	6.27e-05	0.000415	CcSEcCtD
